Free Access
Med Sci (Paris)
Volume 20, Number 8-9, Août-Septembre 2004
Page(s) 727 - 729
Section Nouvelles
Published online 15 August 2004
  1. Dormandy JA, Rutherford, RB. Management of peripheral arterial disease (PAD). TransAtlantic inter-society consensus (TASC) working group. J Vasc Surg 2000; 31 : S1–296. [Google Scholar]
  2. The ICAI Group. Long-term mortality and its predictors in patients with critical leg ischaemia. The study group of criticial chronic ischemia of the lower extremities. Eur J Vasc Endovasc Surg 1997; 14 : 91–5. [Google Scholar]
  3. Isner JM, Pieckzek A, Schainfeld R, et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patients with ischaemic limb. Lancet 1996; 348 : 370–4. [Google Scholar]
  4. Baumgartner I, Pieckzek A, Manor O. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical leg ischemia. Circulation 1998; 97 :1114–23. [Google Scholar]
  5. Shyu KG, Chang H, Wang BW, Kuan P. Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia. Am J Med 2003; 114 : 85–92. [Google Scholar]
  6. Comerota AJ, Throm RC, Miller KA, et al. Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia : preliminary results of a phase I trial. J Vasc Surg 2002; 35 : 930–6. [Google Scholar]
  7. Freedman SB, Isner JM. Therapeutic angiogenesis for coronary artery disease. Ann Intern Med 2002; 136 : 54–71. [Google Scholar]
  8. Losordo DW, Dimmeler S. Therapeutic angiogenesis and veasculogenesis for ischemic disease. Part I : angiogenic cytokines. Circulation 2004; 109 : 2487–91. [Google Scholar]
  9. Krais T, Muller B. Iloprost in pheripheral vascular disease. Cardiovasc Drug Rev 1991; 9 : 158–71. [Google Scholar]
  10. Lederman RJ, Mendelsohn FO, Anderson RD, et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study) : a randomized trial. Lancet 2002; 359 : 2053–8. [Google Scholar]
  11. Takeshita S, Isshiki T, Ochiai M, et al. Endothelium-dependent relaxation of collaterals micorvessels after intramuscular gene transfer of vascular endothelium growth factor in a rat model of hindlimb ischemia. Circulation 1998; 98 : 1261–3. [Google Scholar]
  12. Tsurimi Y, Takeshita S, Chen D, et al. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 1996; 94 : 3281–90. [Google Scholar]
  13. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275 : 964–7. [Google Scholar]
  14. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85 : 221–8. [Google Scholar]
  15. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization Proc Natl Acad Sci USA 2000; 97 : 3422–7. [Google Scholar]
  16. Murohara T, Ikeda H, Duan J, et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000; 105 : 1527–36. [Google Scholar]
  17. Shintani S, Murohara T, Ikeda H, et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 2001; 103 : 897–95. [Google Scholar]
  18. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part II : cell based therapies. Circulation 2004; 109 : 2692–7. [Google Scholar]
  19. Iba O, Matsubara H, Nozawa Y, et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 2002; 106 : 2019–25. [Google Scholar]
  20. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells : a pilot study and a randomised controlled trial. Lancet 2002; 360 : 427–35. [Google Scholar]
  21. Higashi Y, Kimura M, Hara K, et al. Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation 2004; 109 : 1215–8. [Google Scholar]
  22. Huang PP, Li SZ, Han MZ, et al. Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities. Thromb Haemost 2004; 91 : 606–9. [Google Scholar]
  23. Wollert KC, Meyer GP, Lotz J, et al. Randomized controlled clinical trial of intracoronary autologous bone marrow cell transfer post myocardial infarction. Circulation 2003; 108 : 2723 (abstract). [Google Scholar]
  24. Vulliet PR, Greeley M, Halloran SM, et al. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 2004; 363 : 783–4. [Google Scholar]
  25. Kang HJ, Kim HS, Zhang SY, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction : the MAGIC cell randomised clinical trial. Lancet 2004; 363 : 751–6. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.